
    
      A multi-center, double-blind, randomized, placebo controlled, parallel-group study, Adapalene
      Gel 0.1% (Taro Pharmaceuticals U.S.A, Inc.) and to DifferinÂ® Gel (Adapalene 0.1%, Galderma)
      and both active treatments to a placebo control in the treatment of acne vulgaris
    
  